CORRECTING and REPLACING Rite Aid Updates COVID-19 Testing Program
November 24 2020 - 11:04AM
Business Wire
Asymptomatic testing will be available for
individuals 13 and older at existing Rite Aid testing sites
Please replace the release with the following corrected version
due to multiple revisions.
The updated release reads:
RITE AID UPDATES COVID-19 TESTING
PROGRAM
Asymptomatic testing will be available for
individuals 13 and older at existing Rite Aid testing sites
To continue to provide its customers with an essential service
during the pandemic, Rite Aid (NYSE: RAD) is updating its COVID-19
testing program through its partnership with the U.S. Department of
Health and Human Services (HHS). Effective immediately, no-charge
testing at Rite Aid’s existing testing sites will be expanded to
individuals 13 years of age and older – regardless of whether the
individual is symptomatic or asymptomatic.
Rite Aid’s COVID-19 testing locations utilize simple self-swab
nasal tests overseen by Rite Aid pharmacists, and operate Monday
through Friday 10 a.m. - 8 p.m. and Saturday and Sunday 10 a.m. - 5
p.m. At all testing locations, adult patients will be required to
provide government issued identification and need to pre-register
online at www.riteaid.com in order to schedule a time slot for
testing. Testing will be temporarily unavailable at Rite Aid sites
on Thanksgiving and Friday, November 27. Testing will resume on
Saturday, November 28.
Previously, testing was only available to individuals 18 years
of age or older. The expanded program allows parents or legal
guardians of individuals 13-18 years of age to create Baseline
COVID-19 accounts so that they may be screened and tested. Parents
or legal guardians must provide consent for individuals under 18,
show their government issued identification and must accompany
their children to the appointment and supervise them during the
test.
“We’re proud to continue serving as an essential part of the
pandemic response in the neighborhoods we serve,” said Heyward
Donigan, president and chief executive officer, Rite Aid.
“Continuing to make testing available – and now, to a broader age
range – is an important next step in continuing to fight
COVID-19.”
Currently operating 301 testing sites across 15 states, Rite Aid
has been on the front lines of the COVID-19 pandemic, partnering
with Verily and its Baseline COVID-19 Testing Program to provide
screening, scheduling and return of results to participants for
Rite Aid testing sites. BioReference Laboratories provides COVID-19
laboratory testing, while clinical oversight is provided by
PWNHealth, a national clinician network that enables safe and easy
access to diagnostic testing.
Rite Aid will continue to provide regular updates on the
company's progress with COVID-19 testing. A complete list of Rite
Aid’s COVID-19 testing sites can be found at www.riteaid.com.
About Rite Aid Corporation
Rite Aid Corporation is on the front lines of delivering
healthcare services and retail products to more than 1.6 million
Americans daily. Our pharmacists are uniquely positioned to engage
with customers and improve their health outcomes. We provide an
array of whole being health products and services for the entire
family through over 2,400 retail pharmacy locations across 18
states. Through Elixir, we provide pharmacy benefits and services
to approximately 4 million members nationwide. For more
information, www.riteaid.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201124005349/en/
MEDIA: Chris Savarese 717-975-5718
christopher.savarese@riteaid.com
Rite Aid (NYSE:RAD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Rite Aid (NYSE:RAD)
Historical Stock Chart
From Apr 2023 to Apr 2024